All sponsors

Beijing Suncadia Pharmaceuticals Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-34
RECRUITING5
READOUTS ≤12 MONTHS4
Open Beijing Suncadia Pharmaceuticals Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
SHR-1918
NCT07133815
P2Not yet recruitingHomozygous Familial Hypercholesterolemia552025-12
NCT07349615
NCT07349615
P3Active, not recruitingHypertriglyceridemia3672027-03
HRS-4029
NCT07739160
P2RecruitingAcute Ischemic Stroke3402027-04
HRS8179 injection
NCT06732648
P2/3RecruitingSevere Cerebral Edema Following Large Hemispheric Infarction7252027-06
SHR-1918
NCT07230730
P3RecruitingHyperlipidemia9002027-10
SHR-1918 Injection
NCT07404553
P2/3RecruitingHypercholesterolemia1262028-07
SHR-8203 Injection
NCT07769242
P1/2RecruitingSolid Tumors2002029-12-30